---
title: "Alector Q2 FY26 net loss narrows to $23 million; revenue drops to $3.3 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295142189.md"
description: "Alector reported a narrowed Q2 FY26 net loss of $23 million, with revenue dropping to $3.3 million due to lower AL101 AD program recognition. R&D and G&A expenses decreased significantly amid reduced personnel costs. The company holds $172.8 million in cash, ensuring runway through 2027. Additionally, Alector selected AL137 as its lead Alzheimer's candidate, targeting an IND submission in Q1 2027."
datetime: "2026-08-06T20:47:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295142189.md)
  - [en](https://longbridge.com/en/news/295142189.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295142189.md)
---

# Alector Q2 FY26 net loss narrows to $23 million; revenue drops to $3.3 million

-   Alector posted a Q2 net loss of USD 23 million, narrowing from USD 30.5 million a year earlier; loss per share improved to USD 0.21. \* Collaboration revenue fell 57.83% to USD 3.32 million, due to lower revenue recognized for the AL101 AD program. \* R&D expenses dropped 29.51% to USD 19.46 million; G&A expenses slid 42.69% to USD 8.25 million, both on lower personnel costs. \* Cash, cash equivalents and investments totaled USD 172.8 million at June 30; runway expected at least through 2027. \* Selected AL137 as lead ABC-enabled anti-amyloid beta antibody for Alzheimer’s, targeting an IND submission in Q1 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alector Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608061605PRIMZONEFULLFEED9804845) on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ALEC.US](https://longbridge.com/en/quote/ALEC.US.md)

## Related News & Research

- [Alector publishes corporate deck highlighting Brain Carrier platform and neurodegenerative disease pipeline](https://longbridge.com/en/news/295143589.md)
- [Alector (ALEC) Gets a Hold from Mizuho Securities](https://longbridge.com/en/news/292247281.md)
- [Metalfrio Solutions signs off on Q2 2026 financial statements](https://longbridge.com/en/news/296394445.md)
- [Legacy Housing sets 2026 annual shareholder meeting in virtual format](https://longbridge.com/en/news/295958931.md)
- [Alumis publishes corporate deck on next-generation TYK2 inhibitors for immune-mediated diseases](https://longbridge.com/en/news/295970062.md)